Eyelten Therapeutics Overview

  • Founded
  • 2009
Founded
  • Status
  • Out of Business
  • Employees
  • 1
Employees
  • Latest Deal Type
  • Out of Business

Eyelten Therapeutics General Information

Description

Provider of pharmaceutical therapies for the treatment macular degeneration. The company offers medical preparations and treatment options for macular degeneration and other age related problems.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 4041 Forest Park Avenue
  • Saint Louis, MO 63108
  • United States
+1 (314) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Eyelten Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business Completed Out of Business
1. Early Stage VC Completed Startup
To view Eyelten Therapeutics’s complete valuation and funding history, request access »

Eyelten Therapeutics Executive Team (1)

Name Title Board Seat Contact Info
Kunal Rehani President
To view Eyelten Therapeutics’s complete executive team members history, request access »

Eyelten Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial